Patent · US Expired

Thienopyrimidine and thienopyridine derivatives useful as anticancer agents

US6492383B1 · kind B1 · utility

93Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2000
Grant dateDec 10, 2002
Priority date
Expiry dateFeb 10, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of the formulas 1 and 2 and to pharmaceutically acceptable salts and hydrates thereof, wherein X1, R1, R2 and R11 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formulas 1 and 2 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formulas 1 and 2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.